Ask AI
ProCE Banner Activity

An Expert’s Guide to ASCO GI 2023: A Preview of the Top Abstracts

Conference Coverage
Clinical Thought

In this commentary, expert faculty highlight key studies being presented at the upcoming ASCO Gastrointestinal Cancers Symposium. CCO&rsquo s Independent Conference Coverage of ASCO GI 2023 will have the information you need to understand and integrate the latest oncology data into your clinical practice.

Released: January 19, 2023

Continue Activity View Activity

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

This activity is supported by educational grants from

Bristol Myers Squibb

Incyte Corporation

Merck Sharp & Dohme Corp.

Seagen Inc.

Faculty Disclosure

Primary Author

Christopher Lieu, MD, FASCO

Professor of Medicine
Director, GI Medical Oncology
Associate Director for Clinical Research
University of Colorado
Aurora, Colorado

Christopher H. Lieu, MD: researcher: Merck.

Rachna Shroff, MD, MS, FASCO

Chief, Division of Hematology/Oncology, UA COM-T
Associate Director of Clinical Investigations, UACC
Professor of Medicine
University of Arizona Cancer Center (UACC)
University of Arizona College of Medicine - Tucson (UA-COM-T)
Tucson, Arizona

Rachna Shroff, MD, MS: consultant/advisor/speaker: AstraZeneca, Boehringer Ingelheim, Clovis, Genentech, Incyte, Merck, QED Therapeutics, Servier, Taiho, Syros, Zymeworks Biopharm; researcher: Bayer, Bristol-Myers Squibb, Exelixis, IMV, LOXO, Merck, Novocure, Nucana, Pieris, QED Therapeutics, Rafael, Seagen, Taiho.